ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christophe Baufreton
Daniel Y. Loisance
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirsch, M.
Right arrow Articles by Loisance, D. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirsch, M.
Right arrow Articles by Loisance, D. Y.

Ann Thorac Surg 1998;66:417-424
© 1998 The Society of Thoracic Surgeons


Original articles: cardiovascular

Preconditioning with cromakalim improves long-term myocardial preservation for heart transplantation

Matthias Kirsch, MDa, Christophe Baufreton, MD, PhDa, Christine Fernandez, PharmDb, Séverine Brunet, MDa, Fabien Pasteau, MSa, Alain Astier, PhDb, Daniel Y. Loisance, MDa

a Centre de Recherches Chirurgicales Henri Mondor, Créteil, France
b Pharmacie Centrale, Hôpital Henri Mondor, Créteil, France

Accepted for publication February 27, 1998.

Address reprint requests to Dr Loisance, Centre de Recherches Chirurgicales Henri Mondor, Faculté de Médecine, 8 rue du Général Sarrail, 94010 Créteil Cedex, France
e-mail: (loisance{at}univ-paris12.fr)

Background. Myocardial preservation for heart transplantation relies on hyperkalemic cardiac arrest and hypothermic storage. Our study investigated whether pretreatment with a potassium-channel opener (cromakalim) before prolonged storage in an extracellular fluid improves left ventricular recovery.

Methods. Rabbit hearts were submitted to 6-hours’ cold storage and assessed on a blood-perfused isolated heart preparation. Hemodynamic recovery, enzyme release (creatine kinase and lactate dehydrogenase), and adenine nucleotide content were determined. Five groups were tested: control (n = 6), no ischemia; UW group (n = 7), hearts arrested with and stored in University of Wisconsin solution; STH group (n = 5), hearts arrested with and stored in St. Thomas’ Hospital solution; cromakalim group (n = 6), hearts pretreated with cromakalim (30 µg/kg) before arrest with and storage in St. Thomas’ Hospital solution; and glibenclamide group (n = 5), hearts pretreated with cromakalim followed by glibenclamide (a potassium-channel blocker) before arrest with and storage in St. Thomas’ Hospital solution.

Results. Hemodynamic recovery was improved and enzyme release was lower in the UW group than in the STH group. Compared with the STH group, the group pretreated with cromakalim had significantly decreased left ventricular end-diastolic pressures, increased left ventricular developed pressures, increased maximal values of positive and negative rates of rise of left ventricular pressure, and increased time constant of isovolumetric relaxation. Hemodynamic recovery was similar in the UW group and cromakalim groups. Glibenclamide did not abolish the effects of cromakalim. None of the protocols affected myocardial energy stores.

Conclusions. Pretreatment with cromakalim affords additional protection to that provided by cardioplegic arrest and prolonged cold storage using an extracellular solution. The intracellular mechanisms involved remain to be determined.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Z. Ren, Q. Yang, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He
ATP-sensitive potassium channel openers may mimic the effects of hypoxic preconditioning on the coronary artery
Ann. Thorac. Surg., February 1, 2001; 71(2): 642 - 647.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Yellon and A. Dana
The Preconditioning Phenomenon : A Tool for the Scientist or a Clinical Reality?
Circ. Res., September 29, 2000; 87(7): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Penta de Peppo, P. Polisca, F. Tomai, R. De Paulis, F. Turani, E. Zupancich, L. Sommariva, P. Pasqualetti, and L. Chiariello
Recovery of LV contractility in man is enhanced by preischemic administration of enflurane
Ann. Thorac. Surg., July 1, 1999; 68(1): 112 - 118.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Kirsch, S. Bertrand, J.-P. Garnier, C. Fernandez, C. Baufreton, A. Astier, and D. Loisance
Pretreatment with a potassium-channel opener before prolonged cardiac storage: an evaluation in an experimental brain death model
Ann. Thorac. Surg., June 1, 1999; 67(6): 1623 - 1629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.